Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

Phase 4 Completed 20 enrolled University of Virginia

RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome (condition that leads to repeated and severe bouts of vomiting).

Timeline

Start: 2020-12-01
Primary completion: 2022-03-18
Completion: 2022-03-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capsaicin	Small molecule	0.075 %	Topical

Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

Summary

Timeline

Drugs

Indications